Jefferies: 'We appreciate and agree with what HIMS mgmt is doing'

Jefferies analyst Glen Santangelo reiterated a Hold rating and $16.00 price target on Hims and Hers (NYSE: HIMS).

The analyst comments "We appreciate and agree with what HIMS mgmt is doing...expanding overseas to bolster growth and diversify its business, shifting the narrative/strategy toward holistic and personalized health, and underscoring the need for affordable access to healthcare/medications in the US. That said, investors are jittery, so the EBITDA guidance mid-pt miss, despite a solid rev outlook, understandably translates to NT stock pressure. Legal overhang keeps us at Hold."

For an analyst ratings summary and ratings history on Hims and Hers click here. For more ratings news on Hims and Hers click here.

Shares of Hims and Hers closed at $15.51 yesterday.

You May Also Be Interested In

• Stripe, Advent In Talks To Buy Paypal - WSJ
• Cantor Fitzgerald Reiterates Overweight Rating on Applied Materials (AMAT)
• AI/ML Innovations plans $2M private placement on the CSE